{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:44:59Z","timestamp":1773290699533,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.drugalcdep.2013.07.018","type":"journal-article","created":{"date-parts":[[2013,8,17]],"date-time":"2013-08-17T20:15:40Z","timestamp":1376770540000},"page":"494-501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Economic evaluation: A comparison of methadone versus buprenorphine for opiate substitution treatment"],"prefix":"10.1016","volume":"133","author":[{"given":"Jim","family":"Maas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garry","family":"Barton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivienne","family":"Maskrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayley","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0005","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1360-0443.2009.02539.x","article-title":"Comparison of costs and utilization among buprenorphine and methadone patients","volume":"104","author":"Barnett","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0376-8716(99)00117-9","article-title":"Validation of the Christo Inventory for Substance-misuse Services (CISS): a simple outcome evaluation tool","volume":"59","author":"Christo","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0015","series-title":"Analisi dei costi di Buprenorfina vs. Metadone nella terapia dei soggetti con dipendenza da oppiacei","author":"Colombo","year":"2003"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0020","series-title":"Methadone and Buprenorphine for the Management of Opioid Dependence: A Systematic Review and Economic Evaluation","author":"Connock","year":"2007"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0025","series-title":"Unit Costs of Health and Social Care 2011","author":"Curtis","year":"2011"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0030","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2005"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0035","article-title":"The EMCDDA annual report 2010: the state of the drugs problem in Europe","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2010","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0040","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.ajog.2012.10.289","article-title":"Buprenorphine vs. methadone for maintenance of opioid addiction during pregnancy: a cost-effectiveness analysis","volume":"208","author":"Fowler","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00019053-200523010-00007","article-title":"A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting","volume":"23","author":"Harris","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0050","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2008.07.013","article-title":"Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients","volume":"99","author":"Jones","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0055","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1521-0391.2010.00086.x","article-title":"Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment","volume":"19","author":"Maremmani","year":"2010","journal-title":"Am J Addict"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2191-1991-2-3","article-title":"Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone\u00ae) in Spain","volume":"2","author":"Martinez-Raga","year":"2012","journal-title":"Health Econ Rev"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0065","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2008","journal-title":"Cochrane Database Syst Rev C"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0070","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/j.1360-0443.2011.03503.x","article-title":"Using \u2018payment by results\u2019 to fund the treatment of dependent drug users \u2013 proceed with care","volume":"106","author":"Maynard","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0075","series-title":"Electronic Drug Tariff","author":"National Health Service England and Wales","year":"2010"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0080","series-title":"Methadone and Buprenorphine for the Management of Opiod Dependence","author":"National Institute for Health and Clinical Excellence","year":"2010"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0085","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jsat.2010.07.009","article-title":"The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment","volume":"39","author":"Pinto","year":"2010","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0090","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3109\/10826088409061990","article-title":"Screening drug abuse clients with the brief symptom inventory","volume":"19","author":"Royse","year":"1984","journal-title":"Intl J Addict"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0095","doi-asserted-by":"crossref","first-page":"A61","DOI":"10.1016\/j.jval.2013.03.1581","article-title":"A cost-effectiveness analysis of extending methadone and buprenorphine-naloxone maintenance treatment of opioid dependence from eight to sixteen months","volume":"16","author":"Russell","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.addbeh.2005.05.016","article-title":"A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)","volume":"31","author":"Shanahan","year":"2006","journal-title":"Addict Behav"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0105","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/0954026021000046092","article-title":"Substance misuse among prisoners in England and Wales (Reprinted from Office for National Statistics, 1999)","volume":"15","author":"Singleton","year":"2003","journal-title":"Int Rev Psychiatr"},{"key":"10.1016\/j.drugalcdep.2013.07.018_bib0110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/14659890903490781","article-title":"A study to validate a self-reported version of the ONS drug dependence questionnaire","volume":"16","author":"Uddin","year":"2011","journal-title":"J Subst Use"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871613002834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871613002834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T21:54:17Z","timestamp":1539467657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871613002834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0376871613002834"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.07.018","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic evaluation: A comparison of methadone versus buprenorphine for opiate substitution treatment","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}